Assessing the Value of New Drugs:
Where is Canada Heading
The Industry Perspective

PMPRB Symposium, Ottawa

October 8, 2002, Panel 1

Click here to start


Table of Contents

Assessing the Value of New Drugs: Where is Canada Heading The Industry Perspective

Pharmacoeconomic Guidelines – Experience in Canada

What is Health Outcomes?

The Goal of Health Outcomes

Product Approval Hurdles in Canada

Restrictive Market Access Trends

Pharmacoeconomic Assessments – Experience in Canada

Provincial Listings of Innovative Medicines Launched March 1, 2000 – February 28, 2002

Valuing New Drugs – Directions for the Future?

Additional Considerations

Speech from the Throne

Presentation Author

Terry McCool, Vice President, Corporate Affairs, Eli Lilly Canada Inc.
( http://www.lilly.ca )

PMPRB Email

pmprb@pmprb-cepmb.gc.ca

 

PMPRB Symposium 2002, List of Presentations

http://www.pmprb.com/symposium2002/present-e.html